Lung Cancer Therapeutics Market: Size, Growth, Regional Analysis, And Market Analysis
Lung Cancer: Lung cancer is a fatal lung tumor characterized by uncontrolled cell proliferation in the lung tissues. The most significant risk factor for lung cancer is cigarette smoking. Lung cancer can also be caused by prolonged exposure to cigarette smoke. The diagnosis of lung cancer is verified by a biopsy performed under bronchoscopy or CT guidance. As a result, lung cancer can be treated using chemotherapy, radiation, immunotherapy, surgery, and other methods. Market Growth: From 2021 to 2026, the global Lung Cancer Therapeutics Market is expected to grow at a compound annual growth rate (CAGR) of 6.7 percent, from $9.49 billion in 2021. Lung cancer is becoming more common due to increased financing for research and development of new treatments, increased pollution due to fast industrialization, and increased smokers. As a result, all of these factors have contributed to the market's expansion. However, the market's growth has been stifled by adverse drug therapy effe